Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
August 16, 2017 – The FDA announced the discontinuation of Teva’s QVAR (beclomethasone dipropionate HFA) inhalation aerosol due to business reasons.
Download PDF
Return to publications
